Ami Fadia
Stock Analyst at Needham
Total Price Targets
22
Stocks Covered
11
Sectors
Healthcare
Most Recent
Mar 6, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Ami Fadia
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| GHRS | GH Research PLC | $32.00 | $20.60 | +55.3% | 1 | Mar 6, 2026 |
| JAZZ | Jazz Pharmaceuticals plc | $235.00 | $202.38 | +16.1% | 2 | Jan 12, 2026 |
| PRAX | Praxis Precision Medicines, Inc. | $460.00 | $330.59 | +39.1% | 4 | Jan 5, 2026 |
| AXSM | Axsome Therapeutics, Inc. | $225.00 | $204.09 | +10.2% | 1 | Jan 5, 2026 |
| NBIX | Neurocrine Biosciences, Inc. | $184.00 | $131.64 | +39.8% | 1 | Oct 29, 2025 |
| DFTX | Definium Therapeutics, Inc. | $28.00 | $21.83 | +28.3% | 1 | Oct 13, 2025 |
| ACAD | ACADIA Pharmaceuticals Inc. | $30.00 | $21.95 | +36.6% | 3 | May 19, 2025 |
| BIIB | Biogen Inc. | $270.00 | $186.69 | +44.6% | 5 | Feb 12, 2025 |
| RVMD | Revolution Medicines, Inc. | $61.00 | $140.52 | -56.6% | 2 | Aug 8, 2024 |
| NMRA | Neumora Therapeutics, Inc. Common Stock | $23.00 | $2.53 | +809.1% | 1 | Jul 22, 2024 |
| HRMY | Harmony Biosciences Holdings, Inc. | $52.00 | $31.74 | +63.8% | 1 | May 1, 2024 |
Recent Activity
- Mar 6, 2026— Set$32.00price target onGHRS(GH Research PLC)
- Jan 12, 2026— Set$235.00price target onJAZZ(Jazz Pharmaceuticals plc)
- Jan 5, 2026— Set$225.00price target onAXSM(Axsome Therapeutics, Inc.)
- Jan 5, 2026— Set$460.00price target onPRAX(Praxis Precision Medicines, Inc.)
- Dec 5, 2025— Set$304.00price target onPRAX(Praxis Precision Medicines, Inc.)
- Oct 29, 2025— Set$184.00price target onNBIX(Neurocrine Biosciences, Inc.)
- Oct 13, 2025— Set$28.00price target onDFTX(Definium Therapeutics, Inc.)
- May 19, 2025— Set$30.00price target onACAD(ACADIA Pharmaceuticals Inc.)
- Feb 12, 2025— Set$270.00price target onBIIB(Biogen Inc.)
- Sep 4, 2024— Set$75.90price target onPRAX(Praxis Precision Medicines, Inc.)
- Aug 14, 2024— Set$72.90price target onPRAX(Praxis Precision Medicines, Inc.)
- Aug 8, 2024— Set$61.00price target onRVMD(Revolution Medicines, Inc.)
- Jul 22, 2024— Set$23.00price target onNMRA(Neumora Therapeutics, Inc. Common Stock)
- May 1, 2024— Set$52.00price target onHRMY(Harmony Biosciences Holdings, Inc.)
- Apr 12, 2024— Set$46.00price target onRVMD(Revolution Medicines, Inc.)
- Mar 12, 2024— Set$32.00price target onACAD(ACADIA Pharmaceuticals Inc.)
- Jan 24, 2024— Set$37.00price target onACAD(ACADIA Pharmaceuticals Inc.)
- Sep 28, 2022— Set$250.00price target onBIIB(Biogen Inc.)
- Apr 11, 2022— Set$262.00price target onBIIB(Biogen Inc.)
- Mar 3, 2022— Set$215.00price target onJAZZ(Jazz Pharmaceuticals plc)
Frequently Asked Questions
Who is Ami Fadia?
Ami Fadia is a stock analyst at Needham covering 11 stocks primarily in Healthcare. They have issued 22 price targets since Jan 30, 2022.
What stocks does Ami Fadia cover?
Ami Fadia currently covers 11 stocks, including BIIB, PRAX, ACAD, JAZZ, RVMD.
What is Ami Fadia's latest price target?
Ami Fadia's most recent price target was $32.00 on GHRS (GH Research PLC), set on Mar 6, 2026.
What is Ami Fadia's highest price target?
Ami Fadia's highest issued price target is $460.00 on PRAX, set on Jan 5, 2026.
More Analysts at Needham
Coverage based on publicly published price targets. Not investment advice.